Health Canada investigating the long-term safety profile of Xolair
Submitted by Mohit Joshi on Sat, 08/15/2009 - 10:59
Xolair, manufactured by Novartis Pharmaceuticals Canada, is used for the treatment of asthma in people 12 years old and older who have moderate to severe persistent asthma, who react to airborne allergens and whose symptoms are not adequately controlled with inhaled corticosteroids.
Pollution-related asthma may be contracted in the womb
Submitted by Mohit Joshi on Sat, 02/14/2009 - 14:13
Washington, February 14: A new study conducted by researchers from the University of Cincinnati (UC) and Columbia University Mailman School of Public Health suggests that pollution-related asthma may start in the womb.
Gut worm may help treat asthma
Submitted by Mohit Joshi on Thu, 01/29/2009 - 11:18
London, Jan 29 : The humble worm could hold the key to wiping out asthma and other conditions which are on the rise due to the modern mania with cleanliness, reckon scientists.
Researchers in Nottingham are currently investigating whether giving hook worms to asthma sufferers can cure their condition.
Fast-food diet negates breastfeeding benefits in preventing asthma
Submitted by Mohit Joshi on Tue, 01/27/2009 - 16:17
Washington, Jan 27 : While breastfeeding appears to reduce the chance of children developing asthma, a new study has revealed that eating fast food more than once or twice a week cancels out the beneficial effects that nursing has in protecting children from the respiratory disease.
Study opposes current drug treatment for asthma management
Submitted by Mohit Joshi on Tue, 01/27/2009 - 12:25Washington, January 27: A study from the University of Houston in the United States supports a controversial theory that opposes medicines that are presently in use for asthma management.
Research leader Richard A. Bond, professor of pharmacology, has revealed that present-day drugs work by stimulating a receptor found in many cells, including the smooth muscle lining the airways.
He says that while experimenting on mice, his team noticed that the animals that lacked a gene crucial for the production of this receptor did not show any symptoms of asthma.
Anti-fungal medication may benefit patients with severe asthma
Submitted by Mohit Joshi on Mon, 12/29/2008 - 14:01
Washington, Dec 29 : Patients with severe asthma who are allergic to certain fungi may benefit from an anti-fungal drug, says a new study.
Researchers from the University of Manchester in England have found that the drug used to treat fungal infections have shown to greatly improve in patients with severe asthma with fungal sensitization, or "SAFS".
Obese kids are at ‘increased asthma risk’
Submitted by Mohit Joshi on Fri, 12/12/2008 - 15:26
Washington, Dec 12 : Kids with high levels of body fat and lower levels of physical activity are at an increased risk of developing asthma, says a new study.
Study links blacks' birthplace to asthma
Submitted by Mohit Joshi on Tue, 12/02/2008 - 14:32
BOSTON, Dec. 2 - A study of blacks living in a Boston-area community found those born in the United States were more likely to have asthma than those born elsewhere.
